Back to the main directory
EarningsReview / Equity
- Q120 postview (+15 questions for management) by BNP Paribas Exane
- Sinopec (386 HK/600028 CH) by HSBC
- The right move by BNP Paribas Exane
- Lundin Energy - Great company, demanding valuation by Danske Bank Equity Research
- Somebody must be wrong by BNP Paribas Exane
- Össur - Every cloud has a silver lining by Danske Bank Equity Research
- A high price for a place to hide by BNP Paribas Exane
- The only certainty is...uncertainty by BNP Paribas Exane
- Taiwan Mobile (3045 TT) by HSBC
- China Eastern Airlines (670 HK/600115 CH) by HSBC
- Not yet there by BNP Paribas Exane
- Medistim (Sell, TP: NOK160.00) - Strong report, but headwinds next by DnB Markets
- Konecranes (Buy, TP: EUR25.00) - On the weaker side by DnB Markets
- Lundin Mining (Buy, TP: SEK58.00) - Set to benefit from higher prices by DnB Markets
- Nordea (Buy, TP: SEK81.00) - Robust into downturn by DnB Markets
- Telenor (Hold, TP: NOK164.00) - Earnings headwinds by DnB Markets
- Novo Nordisk (Buy, TP: DKK500.00) - by DnB Markets
- DNB (No_rec, TP: NOK) - Set for elevated losses in 2020 by DnB Markets
- Danske Bank (Buy, TP: DKK100.00) - Likely to improve from a weak Q1 by DnB Markets
- Tax proposal short of industry expectations; development companies to benefit most by DnB Markets
- Telekom Austria (TKA AV) by HSBC
- Aker Solutions - Too early to turn bullish by Danske Bank Equity Research
- Asset Management to remain part of Euromoney by BNP Paribas Exane
- EU Taxonomy progresses by BNP Paribas Exane
- Spar Nord Bank - Hold: Not much was positive in Q1 by Nordea